Illumina Ventures Adds Two New Experts as Advisors

Illumina Ventures, a leading genomics and precision health venture firm, today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team ...

Illumina Ventures Adds Two New Experts as Advisors - Yahoo Finance

SAN FRANCISCO, July 18, 2024--Illumina Ventures today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team as ...

News - Illumina Ventures

Spotlight on Susan Tousi – CEO DELFI Diagnostics October 2024 · Spotlight on Brian McKernan – CEO Fluent BioSciences September 2024 · Illumina Ventures Adds Two ...

Illumina Ventures Adds Two New Experts as Advisors - VCWire

Illumina Ventures, a San Francisco, CA-based genomics and precision health venture firm, announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have ...

Illumina Ventures Adds Two New Experts as Advisors | ILMN Stock ...

Illumina Ventures, a leading genomics and precision health venture firm, has announced the addition of two new advisors: Dr. Timothy Stenzel and Jerry ...

Illumina Ventures Adds Two New Experts as Advisors

SAN FRANCISCO--(BUSINESS WIRE)--Jul 18, 2024--Illumina Ventures, a leading genomics and precision health venture firm, today announced that ...

Illumina Ventures Adds Two New Experts as Advisors – San Diego ...

Illumina Ventures Adds Two New Experts as Advisors ... SAN FRANCISCO–(BUSINESS WIRE)– #biotech–Illumina Ventures today announced that Timothy Stenzel, MD, PhD, ...

Illumina Ventures Adds Two New Experts as Advisors – Biotech ...

Illumina Ventures Adds Two New Experts as Advisors ... SAN FRANCISCO–(BUSINESS WIRE)– #biotech–Illumina Ventures today announced that Timothy Stenzel, MD, PhD, ...

Logo - Illumina Ventures Adds Two New Experts as Advisors

Download. Small JPEG, 300x91, 23.5 KB; Preview JPEG, 144x44, 9.2 KB; Thumbnail JPEG, 120x36, 7.2 KB. Smart Multimedia Gallery.

Illumina Ventures Adds Two New Experts as Advisors | AllSides

Illumina Ventures Adds Two New Experts as Advisors. Business. Posted on AllSides July 18th, 2024. Save for Later. From The Center. Read full storyCheck for Bias.

Illumina Ventures: Home

Illumina Ventures is the leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation.

Illumina Ventures Adds Two New Experts as Advisors

SAN FRANCISCO–(BUSINESS WIRE)– #biotech–Illumina Ventures today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the ...

Illumina Ventures sets out for $300M third fund - Endpoints News

A venture firm with Illumina as its majority investor is charging ahead with its next batch of capital as the DNA sequencing company endeavors.

Illumina Ventures on X: "We are pleased to welcome Timothy ...

We are pleased to welcome Timothy Stenzel, MD, PhD and Jerry Steiner as advisors to our team. Together, they bring more than 60 years of ...

ILMN Company Profile & Executives - Illumina Inc. - WSJ

Illumina to Present Upcoming Strategy Update. Press Release. 07/18/24; Press Release. Illumina Ventures Adds Two New Experts as Advisors. Press Release. 07/16/ ...

ILMN Illumina, Inc. Latest Press Releases

Illumina Ventures Adds Two New Experts as Advisors. Business WireThu, Jul. 18. Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, ...

Illumina Invests in £30M Venture Fund To Advance Breakthroughs ...

Illumina Accelerator, located in both San Francisco and Cambridge, is a company creation engine that partners with entrepreneurs to create genomics startups and ...

Illumina Ventures - Investor Profile, Portfolio & Team - Tracxn

Illumina Ventures - Venture capital firm focused on health tech startups. Portfolio of 48 companies including 2 unicorns.

Illumina Ventures on LinkedIn: #leadership | 52 comments

We are pleased to welcome Timothy Stenzel, MD, PhD and Jerry Steiner as advisors to our team. Together, they bring more than 60 years of ...

Dr. Timos Papagatsias on LinkedIn: Illumina Ventures sets out for ...

Gene&Cell Therapy >> Illumina Ventures sets out for $300M third fund: A venture firm with Illumina as its majority investor is charging ...